Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-01-03 @ 8:23 PM
Study NCT ID:
NCT00094458
Status:
COMPLETED
Last Update Posted:
2017-02-09
First Post:
2004-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
Sponsor:
Centocor Ortho Biotech Services, L.L.C.
Organization:
Study Modules
Identification Module
Status Module
Sponsor Collaborators Module
Oversight Module
Description Module
Conditions Module
Design Module
Arms Interventions Module
Outcomes Module
Eligibility Module
Contacts Locations Module
References Module
Adverse Events Module
Baseline Characteristics Module
Participant Flow Module